Concepedia

K. E. Price

KE

27

Publications

1.1K

Citations

18

H-Index

1957

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol Laboratories (United Kingdom)

Pfizer (United States)

University of South Carolina

K. E. Price is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, medicine, and antimicrobial resistance.

Top concepts

Publications per year

1957–1985

27

Publications

27

Comparison of a new cephalosporin, BMY 28142, with other broad-spectrum beta-lactam antibiotics

R E Kessler, M Bies, R. E. Buck et al. · Antimicrobial Agents and Chemotherapy · 1985 · 159 citations

, , +15

Cefadroxil, a New Broad-Spectrum Cephalosporin

R. E. Buck, K. E. Price · Antimicrobial Agents and Chemotherapy · 1977 · 121 citations · Full text

Activity of BB-K8 (Amikacin) Against Clinical Isolates Resistant to One or More Aminoglycoside Antibiotics

K. E. Price, T. A. Pursiano, M. D. DeFuria et al. · Antimicrobial Agents and Chemotherapy · 1974 · 107 citations · Full text

Amikacin, an Aminoglycoside with Marked Activity against Antibiotic-Resistant Clinical Isolates

K. E. Price, M. D. DeFuria, T. A. Pursiano · The Journal of Infectious Diseases · 1976 · 98 citations

, , +15

Epidemiological studies of aminoglycoside resistance in the U.S.A.

K. E. Price, P. A. Kresel, Louis Farchione et al. · Journal of Antimicrobial Chemotherapy · 1981 · 96 citations

Rows per page

1–5 of 27